Related Experiment Videos

Prevalence of positive anticardiolipin antibody in benign infantile convulsion

K Yoshimura1, T Konishi, H Kotani

  • 1Department of Pediatrics, Tosa Municipal Hospital, 1867 Kou Takaoka-cho, Tosa, 781-1101, Kochi, Japan. qwt11230@nifty.ne.jp

Brain & Development
|August 16, 2001
PubMed

Insights

Anticardiolipin antibodies (aCL) may play a role in pediatric epilepsy, particularly benign infantile convulsions (BIC). Further research into immunological responses in BIC pathogenesis is suggested.

Area of Science:

  • Pediatric Neurology
  • Immunology
  • Epileptology

Background:

  • Epilepsy in children can present with various seizure types.
  • Anticardiolipin antibodies (aCL) have been observed in some epilepsy cases.
  • The specific role of aCL in benign infantile convulsions (BIC) requires further investigation.

Purpose of the Study:

  • To investigate the frequency of anticardiolipin antibody (aCL) positivity in children with epilepsy, with a specific focus on benign infantile convulsions (BIC).
  • To explore the potential link between aCL and the pathogenesis of BIC.

Main Methods:

  • Initial study of 18 children with epilepsy, identifying aCL-positive cases.
  • Subsequent focused study on nine BIC cases (including three from the initial cohort).
  • Analysis of aCL-Immunoglobulin (Ig) G levels and long-term observation of antibody titers.

Main Results:

  • Six of 18 epilepsy cases were aCL-positive, with normal coagulation tests.
  • Eight of nine BIC cases were positive for aCL-IgG.
  • aCL-IgG levels decreased over time in three observed BIC cases.
  • The frequency of aCL-IgG positivity in BIC was significantly higher than in control groups.

Conclusions:

  • A high frequency of aCL-IgG positivity exists in benign infantile convulsions (BIC).
  • These findings suggest a potential role for immunological responses in the pathogenesis of BIC.
  • Further research is warranted to elucidate the specific immunological mechanisms involved.

Related Concept Videos